Skip to Content

AGN-190584 FDA Approval Status

FDA Approved: No
Brand name: AGN-190584
Generic name: pilocarpine
Dosage form: Ophthalmic Solution
Company: Allergan plc
Treatment for: Presbyopia

AGN-190584 (pilocarpine 1.25%) is an optimized ophthalmic solution formulation of the approved cholinergic muscarinic receptor agonist pilocarpine in development for the treatment of presbyopia.

Development Timeline for AGN-190584

DateArticle
Feb 25, 2021Allergan Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.